| ALT | Alanine aminotransferase |
| ALP | Alkaline phosphatase |
| CCR | C-C motif chemokine receptor |
| CMV | Cytomegalovirus |
| CXCL | C-X-C motif chemokine |
| CXCR | C-X-C motif chemokine receptor |
| CYP | Cytochrome P |
| DiHS | Drug-induced hypersensitivity syndrome |
| DM | Diabetes mellitus |
| DRESS | Drug reaction with eosinophilia and systemic symptoms |
| EBV | Epstein-Barr Virus |
| FasL | Fatty acid synthase ligand |
| HHV | Human herpes virus |
| HLA | Human leukocyte antigen |
| HMGB-1 | High mobility group box protein 1 |
| IFN | Interferon |
| IL | Interleukin |
| IP-10 | Interferon γ-induced protein-10 |
| IVIG | Intravenous immunoglobulin |
| MHC | Major histocompatibility complex |
| MPE | Maculopapular exanthema |
| NSAID | Non-steroid anti-inflammatory drug |
| pDC | Plasmacytoid dendritic cell |
| SCAR | Severe cutaneous adverse reaction |
| SJS | Stevens-Johnson syndrome |
| TARC | Thymus activation-related chemokine |
| TCR | T cell receptor |
| TEN | Toxic epidermal necrolysis |
| TEM | Effector memory T cell |
| Th | Helper T cell |
| TNF | Tumor necrosis factor |
| Treg | Regulatory T cell |
| ULN | Upper limit of normal range |